JP2010535486A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010535486A5 JP2010535486A5 JP2010519503A JP2010519503A JP2010535486A5 JP 2010535486 A5 JP2010535486 A5 JP 2010535486A5 JP 2010519503 A JP2010519503 A JP 2010519503A JP 2010519503 A JP2010519503 A JP 2010519503A JP 2010535486 A5 JP2010535486 A5 JP 2010535486A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- leptin
- polypeptide
- nucleic acid
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0715216.8A GB0715216D0 (en) | 2007-08-03 | 2007-08-03 | Leptin |
| US95636007P | 2007-08-16 | 2007-08-16 | |
| PCT/GB2008/002489 WO2009019427A1 (en) | 2007-08-03 | 2008-07-23 | Leptin fusion proteins |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010535486A JP2010535486A (ja) | 2010-11-25 |
| JP2010535486A5 true JP2010535486A5 (enExample) | 2011-09-15 |
Family
ID=38529304
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010519503A Withdrawn JP2010535486A (ja) | 2007-08-03 | 2008-07-23 | レプチン融合タンパク質 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20110092417A1 (enExample) |
| EP (1) | EP2185585A1 (enExample) |
| JP (1) | JP2010535486A (enExample) |
| CN (1) | CN101827858A (enExample) |
| GB (1) | GB0715216D0 (enExample) |
| WO (1) | WO2009019427A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2014502252A (ja) | 2010-09-28 | 2014-01-30 | アミリン・ファーマシューティカルズ，リミテッド・ライアビリティ・カンパニー | 作用持続時間が増した改変ポリペプチド |
| ES2732475T3 (es) * | 2011-07-08 | 2019-11-22 | Aegerion Pharmaceuticals Inc | Polipéptidos modificados por ingeniería genética que tienen una duración potenciada de la acción y una inmunogenicidad reducida |
| JP6006309B2 (ja) | 2011-07-08 | 2016-10-12 | アミリン・ファーマシューティカルズ, リミテッド・ライアビリティ・カンパニーAmylin Pharmaceuticals, Llc | 作用持続期間が増大し、免疫原性が減少した操作されたポリペプチド |
| EP2567959B1 (en) | 2011-09-12 | 2014-04-16 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| TW202417497A (zh) | 2015-10-12 | 2024-05-01 | 美商再生元醫藥公司 | 活化瘦素受體的抗原結合蛋白 |
| EA201991075A1 (ru) | 2016-11-08 | 2019-10-31 | Антигенсвязывающие белки, которые проявляют антагонизм в отношении лептинового рецептора | |
| KR20200100089A (ko) | 2017-12-18 | 2020-08-25 | 리제너론 파마슈티칼스 인코포레이티드 | 렙틴 수용체 및/또는 gp130에 결합하는 이중 특이적 항원 결합 분자 및 이의 사용 방법 |
| LT3773713T (lt) | 2018-04-06 | 2025-08-25 | Regeneron Pharmaceuticals, Inc. | Leptino receptoriaus agonistinis antikūnas, skirtas kaulų masės didinimui subjektui, kuriam pasireiškia medžiagų apykaitos sutrikimas arba hipoleptinemija |
| CN109942716B (zh) * | 2019-04-08 | 2023-05-12 | 河南师范大学 | 一种用于治疗代谢疾病的瘦素融合蛋白及其制备方法和应用 |
| CN111848774B (zh) * | 2020-08-05 | 2022-05-10 | 武汉海特生物制药股份有限公司 | 一种美曲普汀的制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL122818A0 (en) * | 1997-07-10 | 1998-08-16 | Yeda Res & Dev | Chimeric interleukin-6 soluble receptor/ligand protein analogs thereof and uses thereof |
| US7446183B2 (en) * | 2000-06-16 | 2008-11-04 | Asterion Limited | Fusion protein comprising growth hormone and growth hormone receptor |
| KR20090006221A (ko) * | 2004-07-26 | 2009-01-14 | 아스테리온 리미티드 | 연결체들 |
| WO2007080404A2 (en) * | 2006-01-12 | 2007-07-19 | Asterion Limited | Leptin ligand |
-
2007
- 2007-08-03 GB GBGB0715216.8A patent/GB0715216D0/en not_active Ceased
-
2008
- 2008-07-23 EP EP08776011A patent/EP2185585A1/en not_active Withdrawn
- 2008-07-23 US US12/671,979 patent/US20110092417A1/en not_active Abandoned
- 2008-07-23 CN CN200880110351A patent/CN101827858A/zh active Pending
- 2008-07-23 WO PCT/GB2008/002489 patent/WO2009019427A1/en not_active Ceased
- 2008-07-23 JP JP2010519503A patent/JP2010535486A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021508449A5 (enExample) | ||
| JP2017527272A5 (enExample) | ||
| JP2023506454A5 (enExample) | ||
| ES3064850T3 (en) | Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo | |
| JP2020534352A5 (enExample) | ||
| CA3072051A1 (en) | Affinity-based methods for using transferrin receptor-binding proteins | |
| WO2008000516B1 (en) | IMPROVED sgp130Fc DIMERS | |
| JP2023528207A5 (enExample) | ||
| JP2020503262A5 (ja) | アクチビンＩＩａ型受容体変異体および同変異体を含む医薬組成物 | |
| FI3368555T3 (fi) | Kaksitoimisia proteiineja ja niitä sisältävä farmaseuttinen koostumus | |
| WO2014130722A1 (en) | Methods and compositions for treatment of forbes-cori disease | |
| RU2014101697A (ru) | Коагонисты рецепторов глюкагона/glp-1 | |
| JP2019507589A5 (enExample) | ||
| JP2019530441A5 (enExample) | ||
| JP2007505643A5 (enExample) | ||
| JP2010526551A5 (enExample) | ||
| JP2017533194A5 (enExample) | ||
| HRP20240135T1 (hr) | Fgf21 mutanti i njihove upotrebe | |
| JP2010529860A5 (enExample) | ||
| ES2562425T3 (es) | Proteínas de fusión terapéuticas | |
| RU2009148020A (ru) | ОПТИМИЗИРОВАННЫЙ СЛИТЫЙ БЕЛОК TACI-Fc | |
| JP2004524810A5 (enExample) | ||
| RU2018119141A (ru) | Слитые с fgf21 белки длительного действия и содержащая их фармацевтическая композиция | |
| JP2010534060A5 (enExample) | ||
| CA2560278A1 (en) | Modified bouganin proteins, cytotoxins and methods and uses thereof |